Your browser doesn't support javascript.
loading
Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection.
Bellusci, Lorenza; Golding, Hana; Khurana, Surender.
Affiliation
  • Bellusci L; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
  • Golding H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
  • Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
JAMA Netw Open ; 6(8): e2327307, 2023 08 01.
Article in En | MEDLINE | ID: mdl-37540517
This cross-sectional study compares the neutralizing titers of convalescent plasma and hyperimmune anti­SARS-CoV-2 intravenous immunoglobulins against circulating Omicron subvariants.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2023 Document type: Article Country of publication: